DOD's Drug Price Controls Unfair, DC Circ. Hears

Law360, New York (May 3, 2012, 4:25 PM EDT) -- A government contractor trade group on Wednesday urged the D.C. Circuit to reverse a ruling upholding the U.S. Department of Defense's authority to impose involuntary price controls on drugmakers for drugs covered under the military’s Tricare health care program that beneficiaries purchase from retail pharmacies.

The Coalition for Common Sense in Government Procurement said involuntary price controls weren’t Congress' intent when it said retail pharmacy purchases by Tricare beneficiaries were subject to the same pricing standards for drugs the DOD purchases directly from drugmakers for use...
To view the full article, register now.